Nu Skin (NUS)
Sells beauty, wellness, and ageLOC device products through social direct selling.
$4.72
vs last close−0.14 (−2.88%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 499 | 489 | 417 | 439 | 430 | 446 | 364 | 386 | 364 | 370 | 321 | 320 |
| Cost of revenue | 207 | 136 | 123 | 132 | 129 | 166 | 118 | 120 | 107 | 108 | 106 | 102 |
| Gross profit | 292 | 352 | 294 | 307 | 301 | 279 | 247 | 266 | 257 | 262 | 214 | 218 |
| 319 | 336 | 285 | 433 | 283 | 332 | 257 | 235 | 235 | 239 | 209 | 278 | |
| Research & development | 0 | 23 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 11 | 0 | 0 |
| 319 | 326 | 278 | 283 | 283 | 286 | 232 | 235 | 235 | 239 | 209 | 199 | |
| Selling & marketing | 188 | 181 | 154 | 165 | 168 | 165 | 119 | 128 | 130 | 131 | 110 | 108 |
| General & administrative | 131 | 145 | 125 | 118 | 116 | 121 | 113 | 107 | 105 | 107 | 99 | 91 |
| Other expenses | 0 | −13 | 7 | 149 | 0 | 33 | 25 | 0 | 0 | −11 | 0 | 79 |
| Operating income | −26 | 16 | 9 | −126 | 18 | −53 | −10 | 31 | 22 | 23 | 6 | −59 |
| −8 | −7 | −8 | −6 | −5 | −5 | 145 | −3 | −6 | −5 | −3 | −4 | |
| Interest income | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 8 | 0 | 7 | 7 | 7 | 6 | 3 | 3 | 4 | 4 | 4 | 3 |
| Other non-operating income | 8 | 7 | 0 | −1 | −2 | −1 | −148 | 1 | 2 | 1 | −1 | 1 |
| Income before tax | −34 | 9 | 1 | −132 | 13 | −58 | 135 | 27 | 16 | 18 | 3 | −63 |
| Income tax expense | 3 | 2 | 2 | −13 | 5 | −22 | 27 | 6 | −1 | 4 | 1 | 187 |
| Net income from continuing operations | −37 | 7 | −1 | −118 | 8 | −36 | 108 | 21 | 17 | 14 | 2 | −250 |
| Net income | −37 | 7 | −1 | −118 | 8 | −36 | 108 | 21 | 17 | 14 | 2 | −250 |
| EPS, basic | −$0.74 | $0.15 | −$0.01 | −$2.38 | $0.17 | −$0.73 | $2.16 | $0.43 | $0.35 | $0.30 | $0.04 | −$5.14 |
| EPS, diluted | −$0.74 | $0.15 | −$0.01 | −$2.38 | $0.17 | −$0.73 | $2.14 | $0.43 | $0.34 | $0.29 | $0.04 | −$5.14 |
| Weighted average shares, basic | 50 | 49 | 50 | 50 | 50 | 50 | 50 | 49 | 49 | 49 | 48 | 49 |
| Weighted average shares, diluted | 50 | 49 | 50 | 50 | 50 | 50 | 50 | 49 | 50 | 50 | 49 | 49 |
| EBITDA | −16 | 27 | 27 | −107 | 37 | −35 | 152 | 43 | 32 | 35 | 19 | −47 |
| Depreciation & amortization | 18 | 17 | 18 | 18 | 17 | 16 | 14 | 13 | 12 | 13 | 12 | 13 |
| EBIT | −34 | 9 | 8 | −125 | 20 | −52 | 138 | 30 | 20 | 22 | 7 | −60 |
